{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:53:09Z","timestamp":1790963589565,"version":"4.1.0"},"reference-count":99,"publisher":"Informa UK Limited","issue":"11","funder":[{"DOI":"10.13039\/100001219","name":"Lymphoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AIDS Malignancy Consortium"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2022,9,19]]},"DOI":"10.1080\/10428194.2022.2086244","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T18:31:26Z","timestamp":1655317886000},"page":"2515-2527","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies"],"prefix":"10.1080","volume":"63","author":[{"given":"David","family":"Qualls","sequence":"first","affiliation":[{"name":"Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kumar","sequence":"additional","affiliation":[{"name":"Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Epstein-Peterson","sequence":"additional","affiliation":[{"name":"Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"issue":"17","key":"CIT0001","first-page":"1903","volume":"130","author":"Eskelund CW","year":"2017","journal-title":"Blood J Am Soc Hematol"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-151831"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1357177"},{"key":"CIT0004","unstructured":"MCL Cells in Tumor Microenvironment Impair T-Cell Metabolic Fitness and Effector Function. ASH; 2020."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010527"},{"issue":"7","key":"CIT0006","first-page":"2537","volume":"110","author":"Yang ZZ","year":"2007","journal-title":"Blood Am Soc Hematol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003871"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.040659"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-185827"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-424630"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-720490"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23199-5"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.071340"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1569231"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.11.012"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.03.005"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21579"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.07.044"},{"issue":"18","key":"CIT0019","first-page":"4890","volume":"118","author":"Chao MP","year":"2011","journal-title":"Blood Am Soc Hematol"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17366"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12409"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2106"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0889"},{"key":"CIT0024","unstructured":"Immune-Depleted Tumor Microenvironment Signature Is Associated with BTK Inhibitor Resistance in Mantle Cell Lymphoma. American Society of Hematology; 2021."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29326"},{"key":"CIT0026","unstructured":"Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R\/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton\u2019s Tyrosine Kinase Inhibitor (BTKi) Therapy. ASH; 2021."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.9585"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14866"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01954.x"},{"key":"CIT0031","unstructured":"CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study. Atlanta, Georgia: ASH; 2021."},{"issue":"2","key":"CIT0032","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2010.08228.x","volume":"150","author":"Romaguera JE","year":"2010","journal-title":"Br J Haematol"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12036"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00542-8"},{"issue":"20","key":"CIT0035","first-page":"4885","volume":"113","author":"Hiraga J","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01035-x"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701122"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1602105"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1403"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3383"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0745"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1255"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23425"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13132"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00438-6"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102089"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07626.x"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505237"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30018-8"},{"issue":"1","key":"CIT0050","first-page":"210","volume":"98","author":"Davies FE","year":"2001","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"CIT0051","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2007.06841.x","volume":"140","author":"Reddy N","year":"2008","journal-title":"Br J Haematol"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15797"},{"issue":"1","key":"CIT0053","first-page":"50","volume":"126","author":"Lagrue K","year":"2015","journal-title":"Blood J Am Soc Hematol"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.119"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0620-4"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12708"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003774"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16414"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-017-0008-6"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1527"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.205229"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002936"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1446"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.220590"},{"key":"CIT0065","unstructured":"Phase 1\/2 Trial of IL7\/IL15-Expanded Bispecific LV20.19 CAR T-Cells for Relapsed, Refractory B-Cell Non-Hodgkin Lymphoma. Atlanta, Georgia: ASH; 2021."},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1081-3"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.02.009"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705074"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.04.013"},{"issue":"18","key":"CIT0070","first-page":"4144","volume":"113","author":"Tam CS","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.05.010"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.04.006"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0067-3"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.102"},{"issue":"6","key":"CIT0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/bjh.15721","volume":"184","author":"Lin RJ","year":"2019","journal-title":"Br J Haematol"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03175"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00889-8"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118344"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136659"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00430-6"},{"key":"CIT0081","volume-title":"A phase IIa, open-label, multicenter study of single-agent tafasitamab (MOR208), an Fc-optimized anti-CD19 antibody, in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma: long-term follow-up, final analysis","author":"Jurczak W","year":"2019"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.7556"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1339"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191712"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-135941"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1002\/hon.57_2629"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07678-4"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14588"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1662"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0463-3"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14920"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0784"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198812"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016004176"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25783"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13818"},{"issue":"7","key":"CIT0098","first-page":"934","volume":"128","author":"Oppermann S","year":"2016","journal-title":"Blood J Am Soc Hematol"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00692-w"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2022.2086244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T06:32:01Z","timestamp":1700721121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2022.2086244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":99,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,9,19]]}},"alternative-id":["10.1080\/10428194.2022.2086244"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2022.2086244","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}